David Cappillo > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
David Cappillo
Position
Partner
Career
David Cappillo is a partner in the firm’s Technology group, and co-chair of the firm’s Healthcare practice, with a primary focus on advising high-growth technology and healthcare companies. He has extensive experience in mergers and acquisitions, venture capital and growth equity, and securities laws. David is a key contributor to Goodwin’s Founders Workbench, an online resource for start-ups, emerging companies and the entrepreneurial community.
David has been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business and has been recognized as a National Law Journal Trailblazer for his Mergers & Acquisitions practice. David has also been included in US News – Best Lawyers for his national emerging company and corporate practice.
Education
JD, 1997, University of Virginia School of Law / BA, 1994, Colgate University (magna cum laude)
Lawyer Rankings
United States > Healthcare > Service providers
Known for its strong focus on transactional issues, Goodwin routinely acts for emerging tech companies, and healthcare and life sciences investors. David Cappillo and Chris Wilson jointly head up the practice from Boston, while James Gatta leads from New York; Cappillo primarily assists tech and healthcare companies with M&A and growth equity issues, Wilson is a private equity expert, and Gatta focuses on both government and internal investigations. Miranda Hooker, John Jones and Allison DeLaurentis all joined the firm as part of a team from Troutman Pepper in early 2023, contributing their expertise in fraud and abuse and governance matters. Greg Demske frequently assists clients with their responses to government investigations and enforcement actions in Washington DC. Delphine O’Rourke left the practice in July 2023.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Shareholder activism